Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHZ: 002399.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Li Li
- Employees
- 1,926
- Headquarters
- Shenzhen, China
- IPO year
- 2010
- Market cap
- CN¥13.6B
- Website
- https://www.hepalink.com
Loading 002399…
Loading profile data…Frequently asked questions about 002399
What does Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) do?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished dose pharmaceutical products, Active Pharmaceutical Ingredients (API), Contract Development and Manufact...
Where does 002399.SZ trade?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002399.SZ in?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.?
Li Li is the chief executive officer of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ).
Where is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. headquartered?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 002399.SZ pay a dividend?
Yes — Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002399.SZ go public?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) completed its initial public offering in 2010.